Checks to make when pharmacy stock arrives

Receiving is a medication-safety checkpoint. A wrong strength or dosage form can enter the shelf unnoticed if staff only count cartons. A repeatable receiving routine catches mismatches before stock is available for dispensing and creates a record that helps investigate shortages, recalls, or temperature excursions.

Match the shipment to the order

Compare the invoice or purchase order with the actual item. Verify the drug name, strength, dosage form, manufacturer or labeler when relevant, package quantity, and number of units. Use the National Drug Code as an additional identifier, not as the sole check: packaging and NDC format can vary, and a code should be interpreted with the product details. Separate look-alike products and strengths during put-away.

Inspect condition and dates

Look for broken seals, moisture, crushed packaging, evidence of tampering, or other damage. Check expiration dates and lot numbers according to the pharmacy’s policy and the product’s requirements. Do not put questionable stock into active inventory until the discrepancy is resolved. Maintain traceability so affected units can be located if a recall or quality notice arrives.

Handle temperature-sensitive products

Vaccines, biologics, and other products may require cold-chain controls. Follow the shipment’s monitoring instructions and the pharmacy’s written receiving procedure. If a logger indicates an excursion, keep the product segregated and at the recommended storage condition while the pharmacist or responsible person obtains manufacturer or distributor guidance. Do not assume that a short excursion is harmless, and do not discard product before following the procedure.

Resolve exceptions before stocking

1. Record shortages, overages, substitutions, damaged packages, and temperature concerns.
2. Keep affected stock identifiable and separate from usable inventory.
3. Notify the pharmacist or inventory lead and contact the supplier when required.
4. Document the resolution, including return, replacement, release, or disposal.
5. Store accepted products promptly under labeled conditions and rotate stock so earlier expirations are used first when appropriate.

At receipt, compare the shipment with the purchase order and invoice: supplier, product, strength, dosage form, quantity, and any controlled or refrigerated handling instructions. Use the pharmacy’s approved process to verify that the trading partner is authorized where DSCSA applies. Check the shipper and package for tampering, damage, temperature indicators, and unexpected substitutions. Do not place an unverified product directly into active stock just because the outside label looks familiar. Keep receiving records linked to the shipment and the person who performed the check.

Inspect product identifiers and package condition

Check the product’s name, NDC, strength, dosage form, lot or batch, expiration date, and serialized package information when applicable. Confirm that the container and tamper-evident features are intact and that labels are legible. A scan may help capture identifiers but does not replace visual inspection. Compare the received quantity against the order and investigate overages, shortages, or duplicate lines before closing the receipt. Keep suspect, illegitimate, damaged, or recalled product segregated and follow the pharmacy’s escalation procedure.

Handle temperature-controlled stock promptly

For vaccines and other temperature-sensitive products, follow the manufacturer’s storage requirements and the facility’s receiving procedure. Record shipment temperature data when required, move acceptable product into monitored storage promptly, and quarantine an excursion rather than guessing that it remains usable. Notify the responsible pharmacist or vaccine coordinator and preserve temperature-monitor data and packaging. Do not return questionable stock to the refrigerator while waiting without clear segregation and labeling; another employee could dispense it by mistake.

Use a controlled quarantine and documentation process

If an item is damaged, recalled, suspect, or discrepant, separate it from saleable stock and mark it so it cannot be selected. Record the reason, product identifiers, lot, quantity, date, and contacts. Follow DSCSA procedures for suspect product investigation and maintain required transaction records. For a recall, use the recall notice’s scope and effectiveness checks rather than removing only the first bottle found. Document final disposition, including return, destruction, or release after the issue is resolved by the authorized person.

Example and recurring mistakes

A shipment contains the correct drug name but a different strength than the order, and the temperature logger shows an excursion for a refrigerated item. Do not receive either item into usable inventory until the discrepancies are resolved; segregate the product, notify the pharmacist, and preserve the shipment record. Common errors include checking only the invoice, overlooking package damage, leaving cold stock at the loading area, or assuming a barcode scan proves authenticity. Receiving is a safety handoff: accuracy at this point protects every later dispensing step.

For routine stock, reconcile order, package, strength, dosage form, quantity, lot, expiry, and visible damage. For serialized prescription drug packages, use the pharmacy’s DSCSA process to verify product tracing information and trading-partner status as applicable. For refrigerated products, check temperature evidence and transfer timing. For controlled substances, use the separate receiving, inventory, and security records required by federal and state rules. One generic “received” scan does not replace these distinct records.

If a supplier, package, or transaction record cannot be verified, segregate the stock and alert the pharmacist or compliance contact. Do not return it to shelves while an investigation is pending. Record who received it, when, and what discrepancy was found. When a recall notice arrives later, the lot and transaction trail help identify affected units and trading partners. Keep the records in the format and for the retention period required by applicable law and the pharmacy’s policy.

Final workflow check

Escalate suspect or illegitimate product concerns,DSCSA defines processes for handling suspect and illegitimate products. A technician who notices inconsistent identifiers, unexplained packaging changes, or a supplier mismatch should immediately notify the pharmacist or designated contact and keep the package segregated. Do not destroy or return it before the investigation instructions are clear. Preserve the transaction documents, images, and contact records needed by the pharmacy’s compliance process.

Key takeaway

Count is only one part of receiving. Verify identity, strength, form, package, condition, traceability, and storage needs before medication enters active stock.